Meeting
2023 ASCO Genitourinary Cancers Symposium
Impact of cytoreductive nephrectomy (CRN) on overall survival (OS) in metastatic non–clear cell renal cancer (nccRCC).
Authors
Ariel Ann Nelson
The Medical College of Wisconsin, Department of Medicine, Division of Hematology and Oncology, Milwaukee, WI
Ariel Ann Nelson , Aniko Szabo , Deepak Kilari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Other
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 730)
DOI
10.1200/JCO.2023.41.6_suppl.730
Abstract #
730
Poster Bd #
L5
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Patient perspectives on cytoreductive nephrectomy after CARMENA.
First Author: Dena Battle
Poster
2017 Genitourinary Cancers Symposium
Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.
First Author: Akhila Ganeshi Wimalasingham
Poster
2024 ASCO Genitourinary Cancers Symposium
Patterns of early 18F-FDG PET response to nivolumab (NIVO) and ipilimumab nivolumab (IPINIVO) in patients with metastatic renal cancer (MRC).
First Author: Natalie Charnley
Poster
2024 ASCO Genitourinary Cancers Symposium
Management, outcomes and predictors of recurrence in chromophobe renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).
First Author: Erica Arenovich